Download PDF

Drug discoveries & therapeutics

Publication date: 2011-12-01
Pages: 279 - 85
Publisher: International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.)

Author:

Zhan, P
Yan, RZ ; Liu, XY ; Pannecouque, Christophe ; Witvrouw, Myriam ; De Clercq, Erik ; Molina, MT ; Vega, S

Keywords:

Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, HIV, pyrazolo[4,5-e][1,2,4] thiadiazine, heterocycle, synthesis, 1115 Pharmacology and Pharmaceutical Sciences, 3214 Pharmacology and pharmaceutical sciences

Abstract:

A series of novel 2,4-disubstituted-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4]thiadiazines (PTDs) was prepared starting from a ring of pyrazolo[4,5-e][1,2,4]thiadiazine nuclei with two different alkyl halides obtained by a facile one-pot reaction. The structures of all synthesized compounds were confirmed by 1H- and 13C-NMR, infrared spectra (IR), and mass spectra (MS) spectroscopic analysis. Anti-HIV activity was evaluated and none of the compounds were found to inhibit HIV replication in human T-lymphocyte (MT-4) cell culture.